Total RNA was extracted from human HepG2 hepatocellular cancer cells treated with proglumide or control media in vitro and subjected to RNA sequencing to analyze selective genes and pathways altered by CCK-B receptor antagonism. This evidence concerns the gene CCKBR and hepatocellular carcinoma.